Tigatuzumab CAS No.918127-53-4
Tigatuzumab CAS No.918127-53-4
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2032 | 1mg | 340.00 | + Add to cart |
|
| R-R-2032 | 2mg | 580.00 | + Add to cart |
|
|
|
||||
Product description
Tigatuzumab (CS-1008)/CAS No.918127-53-4 is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
| Appearance | N/A |
|---|---|
| Molecular Weight | 144.6 (kDa) |
| Purity | >90% |
| CAS | 918127-53-4 |
| Synonyms | CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Tigatuzumab CAS No.918127-53-4
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


